	US 12,337,042 B2
	Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers
Dongyoul Lee, Iowa City, IA (US); Michael K. Schultz, Iowa City, IA (US); Mengshi Li, Iowa City, IA (US); Nicholas Baumhover, Iowa City, IA (US); and F. Christopher Pigge, Iowa City, IA (US)
Assigned to UNIVERSITY OF IOWA RESEARCH FOUNDATION, Iowa City, IA (US)
Filed by University of Iowa Research Foundation, Iowa City, IA (US)
Filed on Jul. 12, 2024, as Appl. No. 18/771,562.
Application 18/771,562 is a continuation of application No. 17/795,792, previously published as PCT/US2021/015389, filed on Jan. 28, 2021.
Claims priority of provisional application 62/967,497, filed on Jan. 29, 2020.
Prior Publication US 2024/0366816 A1, Nov. 7, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 51/10 (2006.01); A61K 51/08 (2006.01); A61P 35/00 (2006.01)

CPC A61K 51/1096 (2013.01) [A61K 51/088 (2013.01); A61K 51/1036 (2013.01); A61P 35/00 (2018.01)]

4 Claims

1. A compound having the following structure: